Comparative analysis of the safety of triple therapy with telaprevir between HCV monoinfected and HIV coinfected patients

Purpose: To know the possible differences in the toxicity profile of triple therapy with telaprevir between monoinfected and coinfected patients. Method: A retrospective observational study (January 2012- November 2013) of patients with HCV genotype 1, both monoinfected and coinfected with HIV, wh...

Full description

Bibliographic Details
Main Authors: C. Sangrador Pelluz, F. J. Maiques Llácer, E. Soler Company
Format: Article
Language:English
Published: Grupo Aula Médica 2014-01-01
Series:Farmacia Hospitalaria
Subjects:
Online Access:http://www.aulamedica.es/fh/pdf/1143.pdf